Further, we generated TGFβ/SMAD4-regulated gene signatures and utilized an in silico mining approach to correlate the identified signatures with clinical outcome data from two publicly available ovarian cancer patient cohorts. The gene discussed is TGFB1; the disease is ovarian cancer.